Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| IMITREX NASAL SPRAY | GLAXOSMITHKLINE INC | Anticipated shortage | 20MG | New Report | 2019-04-18 | 82069 |
| JAMP-ROPINIROLE | JAMP PHARMA CORPORATION | Actual shortage | 5.0MG | Updated Report | 2019-04-18 | 30025 |
| JAMP-ROPINIROLE | JAMP PHARMA CORPORATION | Actual shortage | 5.0MG | Updated Report | 2019-04-18 | 64287 |
| JAMP-ROPINIROLE | JAMP PHARMA CORPORATION | Actual shortage | 1.0MG | Updated Report | 2019-04-18 | 64282 |
| JAMP-PIOGLITAZONE | JAMP PHARMA CORPORATION | Actual shortage | 15MG | Updated Report | 2019-04-18 | 70089 |
| JAMP-PIOGLITAZONE | JAMP PHARMA CORPORATION | Actual shortage | 45MG | Updated Report | 2019-04-18 | 30031 |
| JAMP-PIOGLITAZONE | JAMP PHARMA CORPORATION | Actual shortage | 30MG | Updated Report | 2019-04-18 | 30028 |
| JAMP-OXCARBAZEPINE | JAMP PHARMA CORPORATION | Actual shortage | 600MG | Updated Report | 2019-04-18 | 64276 |
| JAMP-OXCARBAZEPINE | JAMP PHARMA CORPORATION | Actual shortage | 300MG | Updated Report | 2019-04-18 | 64271 |
| JAMP-OXCARBAZEPINE | JAMP PHARMA CORPORATION | Actual shortage | 150MG | Updated Report | 2019-04-18 | 64268 |
| JAMP-LOSARTAN | JAMP PHARMA CORPORATION | Actual shortage | 25MG | Updated Report | 2019-04-18 | 64259 |
| JAMP-LOSARTAN | JAMP PHARMA CORPORATION | Actual shortage | 25MG | Updated Report | 2019-04-18 | 64256 |
| JAMP-LEVETIRACETAM | JAMP PHARMA CORPORATION | Actual shortage | 750MG | Updated Report | 2019-04-18 | 64250 |
| JAMP-LEVETIRACETAM | JAMP PHARMA CORPORATION | Actual shortage | 500MG | Updated Report | 2019-04-18 | 64240 |
| JAMP-LEVETIRACETAM | JAMP PHARMA CORPORATION | Actual shortage | 250MG | Updated Report | 2019-04-18 | 64233 |
| JAMP-CANDESARTAN | JAMP PHARMA CORPORATION | Actual shortage | 32MG | Updated Report | 2019-04-18 | 64208 |
| JAMP-CANDESARTAN | JAMP PHARMA CORPORATION | Actual shortage | 16MG | Updated Report | 2019-04-18 | 64203 |
| JAMP-CANDESARTAN | JAMP PHARMA CORPORATION | Actual shortage | 8MG | Updated Report | 2019-04-18 | 64195 |
| ALVESCO | ASTRAZENECA CANADA INC | Anticipated shortage | 100MCG | Updated Report | 2019-04-18 | 80526 |
| DOSTINEX | PFIZER CANADA ULC | Actual shortage | 0.5MG | Updated Report | 2019-04-18 | 73569 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| STATEX SYRUP 1MG/ML | PALADIN LABS INC | To be discontinued | 1MG | New Report | 2019-04-18 | 81996 |
| STATEX DPS 50MG/ML | PALADIN LABS INC | Discontinued | Updated Report | 2019-04-18 | 81954 | |
| RIVA-OLMESARTAN | LABORATOIRE RIVA INC | Discontinued | 20MG | Updated Report | 2019-04-18 | 81926 |
| RIVA-OLMESARTAN | LABORATOIRE RIVA INC | Discontinued | 40MG | Updated Report | 2019-04-18 | 81929 |
| ULTRAVIST 240 | BAYER INC | Discontinued | 50% | New Report | 2019-04-17 | 81959 |
